89Sr及联合治疗转移性骨肿瘤的临床应用

The clinical application of strontium-89 concomitant use with other modalities in the treatment of bone metastases

  • 摘要: 放射性核素治疗在临床上主要以一种单一的方法在使用,很少作为治疗规范有效地与化学治疗、免疫治疗或者放射治疗联合应用。转移性骨肿瘤的疼痛缓解是近来放射性核素治疗的重要领域,89Sr是常用的治疗这种疾病的放射性核素,它与阿霉素、吉西他滨和顺铂等化疗药物或者放射治疗联合应用后可以增强放射性核素的治疗作用,延长疼痛缓解的时间。这种联合治疗的方法也被用来治疗淋巴瘤、神经母细胞瘤和脑胶质瘤等其他恶性肿瘤,显示出良好的应用前景。

     

    Abstract: Mostly radionuclide therapy was used as a sole method in clinical practice and seldom combined with chemotherapy, immunotherapy or radiotherapy as a treatment procotol. Pain palliation of bone metastases has become a main field in radionuclide therapy in the recent years and strontium-89 is a main radionuclide clinically used. Combining with chemotherapy, doxorubicin, gemcitabin, cisplatin, and radiotherapy can enhance the affect of radionuclide therapy and prolong the period of pain palliation. This con-comitant method was used in the treatment of lymphoma, neuroblastoma and glioma and showed excellent prospect.

     

/

返回文章
返回